Ayala Pharmaceuticals Inc (ADXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -48,072 | -23,399 | -16,060 | -7,361 | -38,013 |
| Depreciation Amortization | 369 | 143 | 99 | 44 | 162 |
| Accounts receivable | 234 | 234 | 234 | 230 | -234 |
| Accounts payable and accrued liabilities | -724 | 1,225 | 588 | -892 | -472 |
| Other Working Capital | 1,104 | -319 | -493 | -520 | 1,097 |
| Other Operating Activity | 17,604 | -167 | 330 | 1,758 | 2,950 |
| Operating Cash Flow | $-29,485 | $-22,283 | $-15,302 | $-6,741 | $-34,510 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 4,000 | N/A | N/A | N/A | N/A |
| Net Acquisitions | 1,909 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 37 | 0 | 0 | 0 | -2 |
| Investing Cash Flow | $5,946 | $N/A | $N/A | $N/A | $-2 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 6,000 | 2,000 | N/A | N/A | N/A |
| Common Stock Issued | 20,001 | 20,001 | 20,001 | N/A | -103 |
| Other Financing Activity | 0 | 0 | 0 | 21,201 | 0 |
| Financing Cash Flow | $26,001 | $22,001 | $20,001 | $21,201 | $-103 |
| Exchange Rate Effect | 26 | -26 | -41 | -36 | N/A |
| Beginning Cash Position | 2,724 | 2,724 | 2,724 | 2,724 | 37,339 |
| End Cash Position | 5,212 | 2,416 | 7,382 | 17,148 | 2,724 |
| Net Cash Flow | $2,488 | $-308 | $4,658 | $14,424 | $-34,615 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,485 | -22,283 | -15,302 | -6,741 | -34,510 |
| Free Cash Flow | -29,485 | -22,283 | -15,302 | -6,741 | -34,510 |